RxDoctor Payments Data

Crystal Martin, MD

Family Medicine · Lexington, KYNPI 1801059332

Payments from drug & device makers

$2,515in general payments, 2019–2025

Across 153 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$429
  • GSK$373
  • Merck$284
  • Astellas Pharma US Inc$230
  • AstraZeneca$204
  • Lilly USA, LLC$181
  • plus $814 from 16 others

What the payments were for

  • Food & beverage$2,43097%
  • Education$853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,515 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,167
Medicare patients
58
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$48,331
EliquisApixaban29$31,755
Breo ElliptaFluticasone/Vilanterol56$31,000
JardianceEmpagliflozin16$22,298
MyrbetriqMirabegron20$21,696
XareltoRivaroxaban12$16,358
RybelsusSemaglutide12$13,751
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,624
Incruse ElliptaUmeclidinium Bromide11$5,223
Paroxetine Hcl14$4,356
DuleraMometasone/Formoterol12$4,028
Varenicline Tartrate12$3,381
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,523
FarxigaDapagliflozin Propanediol17$2,426
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$429$62,08241 claims
GSKBreo Ellipta, Anoro Ellipta, Incruse Ellipta$373$41,84779 claims
PfizerEliquis$13$31,75529 claims
Boehringer IngelheimJardiance$59$22,29816 claims
Astellas Pharma US IncMyrbetriq$230$21,69620 claims
Johnson & JohnsonXarelto$84$16,35812 claims
MerckDulera$284$4,02812 claims
AstraZenecaFarxiga$204$2,42617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →